Tradestie Institutional Equity Comparison Engine

ARIA vs GERN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

GERN Overall Edge

GERN Captures Institutional Edge (3โ€“1 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Geron Corp (GERN) driven by superior Valuation, Growth & Margin, Options & Structure while ARIA counters with relative strength in Momentum & Technical. Fundamentally, ARIA trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus GERN at 48.3x Forward P/E and -7.2% operating margin (+27.4% YoY). In options structure, ARIA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against GERN sits in BREAKDOWN (17th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner GERN
ARIA N/M vs GERN 48.3x Fwd P/E
Growth & Margin Winner GERN
Op Margin N/A vs -7.2% ยท YoY N/A vs +27.4%
Momentum & Technical Winner ARIA
1Y -17.0% vs -18.1% ยท 52W Pos 0% vs 9%
Options & Structure Winner GERN
UNCLASSIFIED (N/A IV) vs BREAKDOWN (17th %ile IV)
ARIA US Equity
ARIA
Institutional Equity
$21.03
-3.52% 1D
Market Cap N/A
1M Return -11.55%
1Y Return -16.97%
Forward P/E N/M
Unified AI Score
47.7 / 100 HOLD
Tech 50.0 Fund 52.0 Flow 50.0 Mom 60.0
GERN NASDAQ
Geron Corp
Pharmaceutical Preparations
$0.94
-2.6% 1D
Market Cap $623.0M
1M Return -19.5%
1Y Return -18.1%
Forward P/E 48.3x
Unified AI Score
54.1 / 100 HOLD
Tech 69.0 Fund 70.0 Flow 71.0 Mom 68.9

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ARIA -16.97% GERN -18.1% Spread: +19.39 pp (ARIA Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ARIA TTM Op. Margin: N/A GERN TTM Op. Margin: -7.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ARIA vs GERN. Trailing 12-month operating profitability (ARIA N/A vs GERN -7.2%) and valuation multiples (ARIA N/M vs GERN 48.3x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ARIA (1) vs GERN (9)
Institutional Metric ARIA GERN Criterion Row Winner
Market Capitalization Scale N/A $623.0M Larger Scale GERN
Trailing P/E Ratio Valuation N/M 48.3x Lower Multiple GERN
Forward P/E Ratio Valuation N/M 48.3x Lower Multiple GERN
Revenue Growth (YoY) Growth N/A +27.4% Higher Growth GERN
Operating Margin (TTM) Profitability N/A -7.2% Higher Margin GERN
Net Profit Margin Profitability N/A -22.0% Higher Margin GERN
Return on Equity (ROE) Capital Efficiency N/A -20.1% Higher ROE GERN
52-Week Range Position Momentum 0% ($21โ€“$27) 9% ($1โ€“$2) Stronger Trend GERN
Beta / 30D Volatility Risk Regime 1.92ฮฒ ยท 43% Vol 1.53ฮฒ ยท 101% Vol Lower Realized Risk ARIA
Unified Institutional Score Composite Signal 47.7 / 100 (HOLD) 54.1 / 100 (HOLD) Higher Composite GERN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ARIA vs GERN Buy Guide
ARIA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ARIA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
GERN BREAKDOWN
72d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 17th %ile
IV Regime Compressed (<25th %ile)
Live GERN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ARIA nor GERN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.